Institutional Best Practices for Treating Schizophrenia

home / peer-exchange / institutional-best-practices-for-treating-schizophrenia

Joe Avelino, RN, BSN, MHSA, CPHQ; Rahn Bailey, MD, DFAPA; and Henry Nasrallah, MD discuss the benefits of long-acting injectables in the management of schizophrenia and system protocols that are in place for the use of long-acting injectables in an institutional setting.

© 2024 MJH Life Sciences

All rights reserved.